Skip to content

Depression: all studies

Page 1016 of 1,035: studies 10,151 to 10,160 of 10,348, newest first. Back to the depression overview

Research

In Vitro Reactivation of Rat Cortical Tryptophan Hydroxylase Following In Vivo Inactivation by Methylenedioxymethamphetamine

Journal of Neurochemistry August 1, 1989 Donna M. Stone, Glen R. Hanson, James W. Gibb

Abstract: The activity of tryptophan hydroxylase (EC 1.14.16.4) from rat brain was significantly decreased 1 h following a single systemic injection of 3,4‐methylenedioxy‐methamphetamine (MDMA) when assessed ex vivo by ra‐dioenzymatic assay or in vivo by the quantitation of 5‐hy‐droxytryptophan accumulation following central L‐aromatic amino acid decarboxylase inhibition. Recovery of enzymatic...

The use of near-death phenomena in therapy.

Journal of Near-Death Studies 1989 Dan Punzak

Though near-death studies have yielded few practical applica tions, some psychotherapists have used insights from near-death experiences (NDEs) to treat a variety of problems.Using hypnosis, relaxation methods, or electric shock to initiate a conversation with a purported spirit "possessing" the patient, the therapist persuades the spirit to join others in a land of ethereal beauty and light...

The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward.

Psychopharmacology 1989 L J Herberg, I C Rose

MK-801 is a ligand at phencyclidine recognition sites associated with NMDA-coupled cation channels, where it acts as a potent noncompetitive antagonist of central glutamate/aspartate (NMDA-type) receptors. Low doses (10-100 micrograms/kg IP) produced a dose-related and prolonged (greater than 1 h) enhancement of variable-interval self-stimulation responding. Higher doses (300 micrograms/kg)...

Effects of intraocular mescaline and LSD on visual-evoked responses in the rat

Pharmacology, Biochemistry, and Behavior 1989 Janis T. Eells, Douglas M. Wilkison 10 citations

The effects of mescaline and LSD on the flash-evoked cortical potential (FEP) were determined in unrestrained rats with chronically-implanted electrodes. Systemic administration of mescaline or LSD significantly attenuated the primary component of the FEP at three stimulus intensities with the greatest effect observed 60-90 minutes following drug administration. The magnitude and specificity of...

Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients

Life Sciences 1989 Ramesh Arora, Herbert Y. Meltzer 175 citations

3H-Lysergic acid diethylamide (3H-LSD) binding, a putative measure of 5-HT2 receptor binding, was studied in the blood platelets of 29 depressed patients and 24 normal controls. The Bmax (maximum number of 3H-LSD binding sites) in the blood platelets of depressed patients was significantly greater than that of normal volunteers. This increase in Bmax was due to an increase in female depressed...

Assessment of the effects of analgesic concentrations of nitrous oxide on human sexual response.

International Journal of Neuroscience November 1, 1988 M A Gillman

The euphorogenic and sexual effects of analgesic nitrous oxide have been long reported anecdotally; however, these effects have only recently been investigated scientifically. The effects of oxygen and analgesic nitrous oxide on sexual arousal provoked by visual erotic stimulation in male (n = 7) and female (n = 6) subjects, using both subjective and objective measures were assessed. Nitrous...

Depressed Mood, Dream Recall and Contentless Dreams

Imagination, Cognition and Personality October 1, 1988 Paul R. Robbins, Roland H. Tanck

The study examined the relation between depressed mood and dream report. Levels of depressed mood were assessed nightly on a sample of ninety college students over a ten-day period using a structured diary. Dream reports were obtained each morning during the ten-day period. Depressed mood tended to be higher preceding nights for which dreams were recalled and described than for nights in which...

The influence of ketamine on regional brain glucose use.

Anesthesiology August 1988 D W Davis, A M Mans, J F Biebuyck et al.

The purpose of this study was to determine the effect of different doses of ketamine on cerebral function at the level of individual brain structures as reflected by glucose use. Rats received either 5 or 30 mg/kg ketamine intravenously as a loading dose, followed by an infusion to maintain a steady-state level of the drug. An additional group received 30 mg/kg as a single injection only, and...

Intrathecal substance P modulates the depressant effect of 5-methoxy-N,N-dimethyltryptamine on a reflex response to radiant heat in mice.

Neuroscience Letters July 19, 1988 P K Eide, K Hole 11 citations

The effect of intrathecal (i.th.) substance P (SP) on antinociception elicited by the serotonin (5-HT) receptor agonist 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) was investigated in mice by means of the tail-flick method. Substance P (0.07, 0.7 or 7 micrograms) induced a behavioral syndrome for 1-2 min, but had no apparent toxic or neurologic effects and did not alter the tail-flick response...

MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.

Journal of Pharmacology and Experimental Therapeutics June 1, 1988 Wouter Koek, James H Woods, Gail Winger

The behavioral effects of MK-801 [(+)-5-methyl-10,11-dihydroxy-5H-dibenzo(a,d)cyclohepten-5,10-imin e], a proposed noncompetitive N-methyl-D-aspartate (NMDA) antagonist, were compared to those of phencyclidine (PCP). In pigeons, MK-801 produced PCP-like catalepsy (i.e., loss of righting without eye closure and without muscle relaxation) and PCP-like discriminative stimulus effects. In rats,...